Rosemary Ikram
Dr Rosemary Ikram is a Consultant Clinical Microbiologist from Christchurch. She graduated from Charing Cross Hospital Medical School and started training as a Microbiologist prior to leaving the UK in 1974. In New Zealand she worked in General Practice and Family Planning for 7 years prior to completing her pathology training at Christchurch Hospital in 1986. She worked as a specialist in Christchurch Hospital until taking up a full time post at Medlab South Ltd. Her key areas of interest are community microbiology and epidemiology. Research topics have included epidemiology of resistant Streptococcus pneumoniae in New Zealand, epidemiology and laboratory diagnosis of infectious diarrhea and more recently antimicrobial resistant organisms in New Zealand. She also runs an Infection Control Service which has a community focus.
Antimicrobial Stewardship in Primary Care Main Session Friday, 15 August 2014 Start 3:15pm Duration: 30mins Plenary Antimicrobial stewardship will be defined. The New Zealand data related to antimicrobial resistance and antimicrobial use in primary care will be reviewed. This will be compared to other countries. Strategies which have been used to improve stewardship will be discussed. Rest Home Infections Main Session Saturday, 16 August 2014 Start 9:15am Duration: 15mins Plenary  Treatment of infections in rest homes involve personal care issues as well as institutional issues ie infection control. This will be discussed using organisms of specific significance in this setting as examples. These will be norovirus, scabies, multiply drug resistant organisms and group A ß haemolytic streptococcus will be used to highlight this. Community Infectious Disease Case Studies Concurrent Workshop Repeated Saturday, 16 August 2014 Start 11:00am Duration: 55mins Room 3 Start 12:05pm Duration: 55mins Room 3 Cases will be used to discuss infections encountered in the general practice setting. Specific infections will be urinary tract infection and colonisation, tinea capitis diagnosis and treatment in the New Zealand community and recurrent staphylococcal infection.